Welcome to the 9th CAR-TCR Summit!

Are you and your team focusing on manufacturing efficiency, solid tumor durability, accessibility, safety, cost-efficiency, product release times, autoimmune indications, armoring, potency assays, resistance or investment for your cell therapy pipelines this year?

The 9th CAR-TCR Summit agenda has been created in collaboration with the cell therapy industry, for the cell therapy industry to address common challenges like these and many more. If you want to discuss these topics with like-minded industry experts and leading academics, then this is the only meeting you need to attend in 2024.

You will gain in-depth insights that are specific to your functional role, whether your focus is on Discovery, Translation, Clinical Development, Early-Stage Manufacturing, Late-Stage Manufacturing, Analytical Development or Supply Chain & Clinical Operations.

Plus, enjoy improved networking opportunities, new bonus days, reduced rates, drinks receptions, scientific poster sessions and more.

With recent expanded approvals for BMS’s Breyanzi and Johnson & Johnson’s Carvykti and further approvals set for this year, join your industry at this pivotal time to celebrate the successes and overcome challenges together to deliver more curative treatments to the ever-growing population of patients in need.

View the Full Agenda to see the speaker faculty, what’s new for 2024, full session details, who you will meet and much more!

2024 Updates:

Reduced Rates
We've streamlined to a 2-day main conference at a lower rate to make the meeting more accessible for the whole industry in tougher financial times.

Solid Tumor &
Automation Focus Days

The two hot topics you asked for: explore methods to Tackle Solid Tumors and streamline scalability and efficiency with Automation & Manufacturing Technology.

Investment & Strategy Bootcamp
Create a bulletproof funding and partnering strategy to safeguard cash runways and support pipeline progression with unheard insights and advice from real investors.

Carl June CAR-TCR
Travel Fund Award

Are you an academic working in the CAR-TCR field? This award enables you to attend the meeting for free to further advance your research, and will be presented live by Dr. Carl June himself! Learn more here.

Signed Up in the Last 2 Weeks:

Your Complete Guide to the Meeting is Here:

9th CAR-TCR Summit - Full Agenda Cover

1,000+ Attendees

No matter which function, stage of development or approach you're working on, you'll meet like-minded peers to workshop your common challenges

130+ Expert Speakers

Learn from pioneering academics, innovative biotechs and heavyweight pharma and gain actionable insights to apply to your work

9+ Hours of Networking

Meet peers, investors, solution providers, and old and new friends across structured sessions, drinks receptions, private lunches, 1-1 meetings and more

7 Refined Tracks

Working in Discovery, Translation, Clinical Development, Early- or Late-Stage Manufacturing, Analytical Development or Supply Chain & Clin Ops?

5 Bonus Days

Take this extra opportunity to deep dive into autoimmune indications, solid tumors, investment, automation and fundamentals

David Sourdive - Cellectis

David Sourdive
Co-Founder & Executive Vice President, CMC & Manufacturing

Cellectis (2)

The summit is a privileged meeting to assess the status, trends, challenges and opportunities in our field, as well as to interact with peers and technology/solution providers... We’re looking forward to the 2024 edition which will shed light on the broadening of CAR-T applicability

150+ Drug Developer Companies Already Signed Up, Including:

9th CAR-TCR Summit - Companies Attending

2024 Expert Speakers Include:

Arun Pores

Arun Pores Fernando
Director, Business Development, Search & Evaluation, Cell Therapy

Bristol Myers Squibb

The 9th CAR-TCR Summit provides a great opportunity to stay up to date on the recent advancements in the ever-expanding Cell therapy space. Looking forward to learning, networking, and sharing insights

Lead Partner

Expertise Partners

Justin McCue

Justin McCue
Chief Technology Officer

TScan Therapeutics

The 9th CAR-TCR Summit provides forums for industry leaders, scientists and related experts in CAR/TCR technology and product development to interact and discuss this fast moving and highly complex field.